Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.33 USD | -2.03% | -2.51% | -6.56% |
05/03 | Top Premarket Gainers | MT |
09/02 | Edesa Biotech, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 14.21M 1.19B |
---|---|---|---|---|---|
Net income 2024 * | -8M -667M | Net income 2025 * | -10M -834M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.9
x | P/E ratio 2025 * |
-2.65
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.65% |
1 day | -2.03% | ||
1 week | -2.51% | ||
Current month | +1.87% | ||
1 month | +0.71% | ||
3 months | -9.15% | ||
6 months | +35.56% | ||
Current year | -6.56% |
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 12/07/12 |
Michael Brooks
PSD | President | 46 | 01/15/01 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 15/23/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 07/19/07 |
Frank Oakes
BRD | Director/Board Member | 73 | 09/10/09 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23/23/23 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 4.27 | -3.39% | 766 |
26/24/26 | 4.42 | -1.09% | 2,308 |
25/24/25 | 4.468 | +3.68% | 2,359 |
24/24/24 | 4.31 | -3.47% | 5,087 |
23/24/23 | 4.465 | +1.94% | 2,343 |
Delayed Quote Nasdaq, April 29, 2024 at 07:05 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.56% | 14.21M | |
-2.06% | 103B | |
+1.61% | 95.28B | |
+3.20% | 22.15B | |
-16.25% | 21.02B | |
-8.38% | 18.15B | |
-41.01% | 16.73B | |
-14.72% | 16.05B | |
+4.43% | 13.68B | |
+34.74% | 12.17B |
- Stock Market
- Equities
- EDSA Stock